October 29, 2019

ASCO Breakthrough

Breast Cancer Gene-Expression Signature May Help Predict Recurrence Postradiotherapy

“Historically, women who have breast cancer that comes back within the first 3 years have significantly worse outcomes, including much higher rates of death from breast cancer. If we can identify these patients before they develop early, aggressive recurrences, we may be able to more effectively treat these patients,” said lead author Corey Speers, MD, PhD, Assistant Professor of Radiation Oncology at the University of Michigan. “This work, while exciting and novel, is still premature and not yet ready for clinical adoption. Validation studies in prospective clinical trials are still needed.”